There are 2867 resources available
1687P - Targeted metabolomics reveals dynamic changes and potential therapeutic targets in the serum metabolome of patients receiving adoptive cell therapy with tumor infiltrating lymphocytes
Presenter: Luke Mantle
Session: Poster session 06
1688P - Selection of PD-L1 escape variants in microsatellite stable metastatic colorectal cancer on avelumab treatment
Presenter: Christoph Schultheiß
Session: Poster session 06
1689P - OATD-02 validates the benefits of pharmacological inhibition of arginase 1 and 2 in cancer
Presenter: Marcin Grzybowski
Session: Poster session 06
1690P - Anticancer effects of PARP1 hyperactivation by a new generation of decoy oligodeoxynucleotide
Presenter: Wael Jdey
Session: Poster session 06
1692P - ImmTAC redirect T cells against patient-derived tumour organoids and three-dimensional melanospheres: Effects augmented by type I interferons
Presenter: Peter Kirk
Session: Poster session 06
1693P - Incidence of NTRK genes fusion in adult brain tumours: A prospective cohort of 140 patients with cerebral gliomas and brain metastases
Presenter: Philippe Métellus
Session: Poster session 06
1694P - Single cell characterization of longitudinal biopsies from breast cancer patients treated with the aromatase inhibitor letrozole and the CDK4/6 inhibitor ribociclib
Presenter: Xavier Tekpli
Session: Poster session 06
1695P - Neutralizing anti-FGFR1 antibody as a combined partner of anti-PD-1 antibodies in tumor models
Presenter: Ilya Tsimafeyeu
Session: Poster session 06
3P - Beyond first-line therapy in metastatic adrenal cortical cancer (ACC): Is it time to move on from chemotherapy?
Presenter: Abhenil Mittal
Session: Poster session 07
4P - Immune checkpoint inhibitors in adrenocortical carcinoma: A meta-analysis
Presenter: Obada Ababneh
Session: Poster session 07